The Hedgehog pathway: role in cell differentiation, polarity and proliferation

Y Jia, Y Wang, J Xie - Archives of toxicology, 2015 - Springer
Hedgehog (Hh) is first described as a genetic mutation that has “spiked” phenotype in the
cuticles of Drosophila in later 1970s. Since then, Hh signaling has been implicated in …

Targeting hedgehog signaling in cancer: research and clinical developments

J Xie, CM Bartels, SW Barton, D Gu - OncoTargets and therapy, 2013 - Taylor & Francis
Since its first description in Drosophila by Drs Nusslein-Volhard and Wieschaus in 1980,
hedgehog (Hh) signaling has been implicated in regulation of cell differentiation …

Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer

I Eke, K Zscheppang, E Dickreuter… - Journal of the …, 2015 - academic.oup.com
Background: Signaling from integrins and receptor tyrosine kinases (RTKs) contributes
substantially to therapy resistance of malignant tumors. We investigated simultaneous β1 …

Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery

L Buckel, EN Savariar, JL Crisp, KA Jones, AM Hicks… - Cancer research, 2015 - AACR
Intrinsic tumor resistance to radiotherapy limits the efficacy of ionizing radiation (IR).
Sensitizing cancer cells specifically to IR would improve tumor control and decrease normal …

Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer

M Lecavalier‐Barsoum, N Chaudary… - … journal of cancer, 2018 - Wiley Online Library
Cervical cancer is the fourth most commonly diagnosed cancer and the fourth leading cause
of cancer death in women worldwide. Approximately half of cervical cancer patients present …

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

SR Adams, HC Yang, EN Savariar, J Aguilera… - Nature …, 2016 - nature.com
Tumour resistance to radiotherapy remains a barrier to improving cancer patient outcomes.
To overcome radioresistance, certain drugs have been found to sensitize cells to ionizing …

[HTML][HTML] Hypoxic jumbo spheroids on-A-Chip (HOnAChip): Insights into treatment efficacy

E Refet-Mollof, O Najyb, R Chermat, A Glory… - Cancers, 2021 - mdpi.com
Simple Summary Hypoxia is found in half of the solid cancers and is a major contributor to
treatment resistance and promotion of metastasis, leading to shortened patient survival. No …

Precision chemoradiotherapy for HER2 tumors using antibody conjugates of an auristatin derivative with reduced cell permeability

DV Hingorani, MK Doan, MF Camargo, J Aguilera… - Molecular cancer …, 2020 - AACR
The most successful therapeutic strategies for locally advanced cancers continue to
combine decades-old classical radiosensitizing chemotherapies with radiotherapy …

Small molecule inhibition of MDM2–p53 interaction augments radiation response in human tumors

LR Werner, S Huang, DM Francis, EA Armstrong… - Molecular cancer …, 2015 - AACR
MDM2–p53 interaction and downstream signaling affect cellular response to DNA damage.
AMG 232 is a potent small molecule inhibitor that blocks the interaction of MDM2 and p53 …

National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer

TJ George, AJ Franke, AB Chakravarthy, P Das… - Cancer, 2019 - Wiley Online Library
Colorectal cancer (CRC) represents a major public health problem as the second leading
cause of cancer‐related mortality in the United States. Of an estimated 140,000 newly …